Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ICCC ImmuCell Corporation daily Stock Chart
ICCC [NASD]
ImmuCell Corporation
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.32 Insider Own0.10% Shs Outstand7.18M Perf Week1.36%
Market Cap37.48M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.17M Perf Month-0.58%
Income-2.00M PEG- EPS next Q- Inst Own20.00% Short Float0.09% Perf Quarter2.86%
Sales13.00M P/S2.88 EPS this Y-775.80% Inst Trans-10.47% Short Ratio0.06 Perf Half Y-11.36%
Book/sh4.05 P/B1.29 EPS next Y- ROA-4.70% Target Price- Perf Year-30.49%
Cash/sh1.34 P/C3.90 EPS next 5Y- ROE-6.40% 52W Range4.70 - 8.13 Perf YTD1.36%
Dividend- P/FCF- EPS past 5Y-67.30% ROI-6.10% 52W High-35.79% Beta1.34
Dividend %- Quick Ratio4.90 Sales past 5Y12.80% Gross Margin48.30% 52W Low11.06% ATR0.33
Employees25 Current Ratio6.10 Sales Q/Q36.40% Oper. Margin-10.50% RSI (14)51.70 Volatility4.36% 5.61%
OptionableNo Debt/Eq0.29 EPS Q/Q-52.90% Profit Margin-13.70% Rel Volume0.12 Prev Close5.20
ShortableYes LT Debt/Eq0.25 EarningsFeb 18 AMC Payout- Avg Volume79.11K Price5.22
Recom- SMA201.21% SMA501.16% SMA200-7.18% Volume9,508 Change0.38%
Feb-19-20 05:58PM  Edited Transcript of ICCC earnings conference call or presentation 19-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
12:35PM  ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019 GlobeNewswire
Feb-18-20 04:05PM  ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019 GlobeNewswire +5.51%
Feb-13-20 09:17AM  ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 GlobeNewswire
Jan-24-20 12:04PM  Why I Love Trading A Small Account, And Why You Should Too Benzinga
08:35AM  Imagine Owning ImmuCell (NASDAQ:ICCC) And Wondering If The 32% Share Price Slide Is Justified Simply Wall St.
Jan-21-20 12:30PM  ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019 GlobeNewswire +19.28%
Jan-06-20 02:25PM  Edited Transcript of ICCC earnings conference call or presentation 11-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-22-19 01:21PM  Hedge Funds Have Never Been More Bullish On ImmuCell Corporation (ICCC) Insider Monkey
Dec-19-19 11:38AM  Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load? Simply Wall St.
Nov-12-19 09:37AM  Does ImmuCell Corporation (NASDAQ:ICCC) Have A Volatile Share Price? Simply Wall St.
Nov-11-19 04:05PM  ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019 GlobeNewswire
Nov-05-19 08:00AM  ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019 GlobeNewswire
Sep-17-19 08:00AM  ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity GlobeNewswire
Sep-11-19 08:00AM  ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain GlobeNewswire
Sep-06-19 11:43PM  Edited Transcript of ICCC earnings conference call or presentation 13-Aug-19 1:00pm GMT Thomson Reuters StreetEvents -6.02%
Aug-29-19 08:00AM  ImmuCell Receives FDA Response To First CMC Submission for Re-Tain GlobeNewswire
Aug-12-19 04:05PM  ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019 GlobeNewswire
Aug-11-19 03:46PM  The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO Benzinga
Aug-06-19 08:00AM  ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 GlobeNewswire
May-21-19 11:20AM  Edited Transcript of ICCC earnings conference call or presentation 14-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-14-19 07:42AM  The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings Benzinga
May-13-19 04:05PM  ImmuCell Announces Unaudited Financial Results for First Quarter of 2019 GlobeNewswire
May-07-19 09:00AM  ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 GlobeNewswire +5.79%
Mar-29-19 11:45AM  ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock GlobeNewswire
Mar-27-19 07:30AM  ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock GlobeNewswire -11.44%
Mar-26-19 04:10PM  ImmuCell Corporation Announces Commencement of Public Offering of Common Stock GlobeNewswire
Mar-22-19 10:48AM  ImmuCell Corp (ICCC) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-07-19 02:04PM  Do Directors Own ImmuCell Corporation (NASDAQ:ICCC) Shares? Simply Wall St.
Feb-28-19 02:00PM  ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product GlobeNewswire
Feb-14-19 07:50AM  The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial Benzinga -6.93%
Feb-13-19 04:05PM  ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018 GlobeNewswire
Feb-06-19 09:27AM  ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018 GlobeNewswire
Jan-11-19 02:00PM  Edited Transcript of ICCC earnings conference call or presentation 14-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Dec-11-18 08:00AM  ImmuCell Announces USDA Approval of Dual-Force First Defense® GlobeNewswire
Nov-23-18 08:00AM  Report: Developing Opportunities within ReWalk Robotics, ImmuCell, SCYNEXIS, Fuel Tech, Garrison Capital, and AMREP Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-13-18 04:05PM  ImmuCell Announces Financial Results for Third Quarter of 2018 GlobeNewswire
Nov-08-18 08:00AM  ImmuCell to Participate at 9th Annual Craig-Hallum Alpha Select Conference GlobeNewswire
Nov-07-18 09:16AM  ImmuCell to Announce Financial Results for Third Quarter of 2018 GlobeNewswire
Sep-26-18 03:25PM  Could ImmuCell Corporations (NASDAQ:ICCC) Investor Composition Impacts Your Returns? Simply Wall St.
Sep-25-18 04:16PM  ImmuCell Announces Issuance of Human Food Safety Technical Section Complete Letter for its Purified Nisin Product GlobeNewswire
Aug-30-18 11:02AM  Edited Transcript of ICCC earnings conference call or presentation 14-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Aug-14-18 07:00AM  ImmuCell Corporation to Host Earnings Call ACCESSWIRE
Aug-13-18 04:05PM  ImmuCell Announces Financial Results for Second Quarter of 2018 GlobeNewswire
Aug-07-18 10:30AM  ImmuCell to Announce Financial Results for Second Quarter of 2018 GlobeNewswire
06:30AM  ImmuCell Hires Senior Director of Quality GlobeNewswire
Jul-25-18 06:30AM  ImmuCell Announces Sale of Certain Non-Core Assets GlobeNewswire
Jul-10-18 06:30AM  ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018 GlobeNewswire +7.18%
Jun-25-18 06:30AM  ImmuCell to Join Russell Microcap Index GlobeNewswire
Jun-07-18 02:02PM  Should You Have ImmuCell Corporations (NASDAQ:ICCC) In Your Portfolio? Simply Wall St.
May-23-18 12:03PM  Edited Transcript of ICCC earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-22-18 07:20AM  Wired News - Stemline Therapeutics' SL-401 BPDCN Program Selected for Clinical Presentations at Upcoming EHA Congress ACCESSWIRE
May-14-18 04:05PM  ImmuCell Announces Financial Results for First Quarter of 2018 GlobeNewswire
12:30PM  ImmuCell Corporation to Host Earnings Call ACCESSWIRE
May-07-18 11:00AM  ImmuCell to Announce Financial Results for First Quarter of 2018 GlobeNewswire
Apr-11-18 02:07PM  Who Are The Largest Shareholders In ImmuCell Corporation (NASDAQ:ICCC)? Simply Wall St.
Mar-05-18 07:55PM  Where ImmuCell Corporation (NASDAQ:ICCC) Stands In Terms Of Earnings Growth Against Its Industry Simply Wall St.
Feb-12-18 07:16AM  Edited Transcript of ICCC earnings conference call or presentation 8-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-08-18 04:05PM  ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017 GlobeNewswire
12:00PM  ImmuCell Corporation to Host Earnings Call ACCESSWIRE
Feb-05-18 05:10PM  ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017 GlobeNewswire
Jan-30-18 06:30AM  ImmuCell Appoints Two New Members to its Board of Directors GlobeNewswire
Dec-25-17 09:31AM  ImmuCell Corp. :ICCC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-21-17 11:00AM  ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock GlobeNewswire
Dec-19-17 06:30AM  ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares GlobeNewswire
Nov-22-17 02:48PM  Edited Transcript of ICCC earnings conference call or presentation 13-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-17 04:05PM  ImmuCell Announces Financial Results for Third Quarter of 2017 GlobeNewswire
11:30AM  ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections GlobeNewswire
Nov-07-17 06:30AM  ImmuCell Announces Completion of Construction of Nisin Production Facility GlobeNewswire
Nov-02-17 11:14AM  ImmuCell to Announce Financial Results for Third Quarter of 2017 GlobeNewswire
Oct-06-17 09:14AM  ImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Oct-05-17 09:16AM  Did ImmuCell Corporation (ICCC) Create Value For Investors Over The Past Year? Simply Wall St.
Sep-13-17 06:30AM  ImmuCell Announces Expansion of Sales and Marketing Team GlobeNewswire
Aug-17-17 10:16PM  Edited Transcript of ICCC earnings conference call or presentation 14-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-17 04:05PM  ImmuCell Announces Financial Results for Second Quarter of 2017 GlobeNewswire
01:00PM  Investor Network: ImmuCell Corporation to Host Earnings Call ACCESSWIRE
Aug-07-17 08:00AM  ImmuCell to Announce Financial Results for Second Quarter of 2017 GlobeNewswire
Jul-27-17 04:05PM  ImmuCell Closes $1,000,000 Equity Investment GlobeNewswire
Jul-17-17 08:00AM  ImmuCell Unveils New Website GlobeNewswire
Jul-13-17 04:05PM  ImmuCell Clarifies Number of Authorized Common Shares GlobeNewswire
Jun-13-17 10:03AM  ImmuCell Corp. :ICCC-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017 Capital Cube
May-19-17 04:56AM  Edited Transcript of ICCC earnings conference call or presentation 11-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-15-17 02:11PM  ImmuCell Corp.: Strong price momentum but will it sustain? Capital Cube
May-12-17 09:05AM  Edited Transcript of ICCC earnings conference call or presentation 11-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-11-17 04:05PM  ImmuCell Announces Financial Results for First Quarter of 2017 Accesswire
May-04-17 08:00AM  ImmuCell to Announce Financial Results for First Quarter of 2017 Accesswire
Apr-04-17 12:18PM  ImmuCell Corp. :ICCC-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017 Capital Cube
12:18PM  ImmuCell Corp. :ICCC-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017
Apr-03-17 07:14AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ImmuCell Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-30-17 03:46PM  IMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report
Mar-08-17 12:44PM  IMMUCELL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Entry into a Material Definitive Ag
08:00AM  Bobbi Jo Brockmann is appointed to Board of Directors of ImmuCell Corporation Marketwired
Mar-02-17 12:06PM  IMMUCELL CORP /DE/ Files SEC form 8-K, Other Events
08:00AM  ImmuCell Secures $2 Million in Debt Financing Marketwired
Feb-14-17 01:44PM  ImmuCell Corp. :ICCC-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017 Capital Cube
01:44PM  ImmuCell Corp. :ICCC-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017
Feb-10-17 08:13AM  IMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
Feb-09-17 04:05PM  ImmuCell Announces Preliminary 2016 Financial Results Marketwired
07:07AM  Q4 2016 ImmuCell Corp Earnings Release - After Market Close
Feb-06-17 12:54PM  ImmuCell to Announce Preliminary 2016 Financial Results Marketwired
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing Re-Tain, a Nisin-based treatment of subclinical mastitis in lactating dairy cows; and offers Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products through animal health distributors. The company was founded in 1982 and is headquartered in Portland, Maine.
open in yahoo | open in reuters | open in google